NADAC acquisition cost data for PROAIR RESPICLICK 90 MCG INHLR. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
| 59310058020 | $63.41 | 2022-03-23 | Rx |
Generic: Albuterol Sulfate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | $99.9K | 552 | 466 | $160.15 |
| 2021 | $282.5K | 1,601 | 1,234 | $153.96 |
| 2022 | $520.8K | 2,970 | 2,228 | $157.33 |
| 2023 | $822.8K | 7,522 | 5,432 | $95.91 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $104.8K | 954 | 644 |
| New York | $77.5K | 724 | 494 |
| Florida | $60.2K | 566 | 456 |
| Texas | $57.8K | 550 | 445 |
| Ohio | $38.3K | 353 | 236 |
| Virginia | $34.1K | 306 | 220 |
| New Jersey | $32.8K | 276 | 199 |
| Indiana | $31.9K | 301 | 213 |
| Kentucky | $27.6K | 210 | 148 |
| Michigan | $26.8K | 252 | 201 |
| Pennsylvania | $25.7K | 240 | 177 |
| Georgia | $25.0K | 226 | 159 |
| Arizona | $21.8K | 192 | 127 |
| North Carolina | $20.7K | 194 | 149 |
| Illinois | $18.4K | 176 | 129 |
| Massachusetts | $17.8K | 172 | 116 |
| Missouri | $16.9K | 160 | 110 |
| Tennessee | $16.5K | 153 | 114 |
| Alabama | $15.1K | 148 | 131 |
| Maryland | $12.8K | 108 | 83 |
| Kansas | $11.9K | 105 | 57 |
| Colorado | $9.9K | 74 | 54 |
| Connecticut | $8.9K | 82 | 53 |
| Washington | $8.3K | 75 | 43 |
| South Carolina | $8.2K | 78 | 62 |
| Oklahoma | $7.8K | 76 | 43 |
| Wisconsin | $7.0K | 65 | 46 |
| West Virginia | $6.7K | 60 | 40 |
| Louisiana | $6.4K | 63 | 45 |
| Nevada | $6.1K | 59 | 45 |
| Oregon | $5.5K | 52 | 38 |
| New Hampshire | $5.3K | 47 | 38 |
| Delaware | $5.0K | 48 | 31 |
| Maine | $4.8K | 41 | 31 |
| Iowa | $4.2K | 34 | 24 |
| Vermont | $4.1K | 39 | 27 |
| Alaska | $3.8K | 18 | 11 |
| Mississippi | $3.7K | 32 | 29 |
| Minnesota | $3.6K | 29 | 15 |
| Arkansas | $3.2K | 31 | 27 |
| New Mexico | $3.2K | 29 | 25 |
| Rhode Island | $2.5K | 24 | 23 |
| Utah | $1.8K | 17 | 15 |
| Idaho | $1.7K | 17 | 16 |
| District of Columbia | $1.6K | 16 | 12 |
| Puerto Rico | $1.4K | 13 | 11 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.